不知不觉中，免疫疗法已经占据了癌症治疗版图的“半壁江山”。从免疫检查点抑制剂到CAR-T细胞疗法，人类对抗癌症的武器正在不断进步。随着CAR-T细胞疗法在血液肿瘤领域“高歌猛进”时，科学家们将目光投向了更具挑战性的实体肿瘤战场。

5 (4) A CAR controlled remotely via drugs and other small molecules puts the brakes on T cell activation and prevents exhaustion. 6,7 (5) The T cell receptor (TCR) is a protein complex that recognizes ...

在国际顶级期刊《自然-医学》最新公布的全球肿瘤治疗趋势报告中，实体瘤治疗失败率较五年前仅下降2.3个百分点，这个数据背后折射出的是全球医疗界持续三十年的困局。当CAR-T疗法在血液肿瘤领域高歌猛进时，实体瘤领域却始终未能突破肿瘤微环境的铜墙铁壁。2025年3月30日广州召开的一场临床试验方案研讨会，或许正在改写这个历史脚本——香雪生命科学TAEST16001的确证性临床试验启动，不仅意味着中国首个 ...

Modern and historic tin-tops starred when the British Automobile Racing Club season began at Donington Park last weekend as ...

Adam Shepherd controlled the first TCR UK race of 2025 at Donington Park despite a safety car interruption, a race which saw ...

Last week, I had the privilege of heading into town in Boston to attend three days of the CAR-TCR conference, a major annual gathering of researchers and industry stakeholders concerned with ...

The industry is brimming with new hope! The 8th CAR-TCR Summit Europe returns to London this February as your must-attend forum to remain on the pulse of recent innovation in cell therapy. Join us to ...